News

Investor's Business Daily on MSN7h
The Next Look At Amgen's Obesity Drug Is Coming. Here's What Investors Are Watching.
Later this month, the Street will have a fresh opportunity to gauge the potential for Amgen's experimental weight-loss drug, MariTide.
Fierce Pharma14h
Fierce Pharma Asia—Bispecific field's roller coaster week; Enhertu's first-line win; Regeneron-Hansoh obesity deal
The PD-(L)1xVEGF field had a roller coaster week marked by an imperfect readout and a potentially $11 billion deal. | The PD- ...